The global topical corticosteroids market continues to witness remarkable growth and holds immense promise for the future. With increasing awareness about skin conditions and advancements in healthcare, the demand for topical corticosteroids is surging. These medications offer effective solutions for various dermatological disorders, providing relief and improving the quality of life for patients worldwide. Supported by ongoing research and development, innovative formulations and delivery methods are further enhancing the efficacy and convenience of topical corticosteroids. As a result, the market is poised for sustained growth, positively impacting the lives of individuals in need.
Access Full Report:- https://www.databridgemarketresearch.com/reports/global-topical-corticosteroids-market
Data Bridge Market Research analyses that the Topical Corticosteroids Market is expected to grow to USD 3,996.91 million in 2022, and is expected to reach USD 6,418.71 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. The increasing incidence of skin conditions, such as eczema, psoriasis, and dermatitis, is a significant driver for the topical corticosteroids market. These medications provide effective relief for symptoms associated with these disorders.
Key Findings of the Study
Growing emphasis on aesthetic dermatology is expected to drive the market's growth rate
The rising emphasis on aesthetic dermatology has fueled the demand for topical corticosteroids in addressing various cosmetic conditions. These medications are increasingly utilized in treating acne, hyperpigmentation, and photo aging, as they offer anti-inflammatory properties, reduce redness, and improve skin texture. Their effectiveness in managing these aesthetic concerns, coupled with advancements in formulations, has made topical corticosteroids an integral part of aesthetic dermatology, meeting the needs and desires of individuals seeking skin enhancement and rejuvenation.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High, Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Gsk plc (U.K.), Almirall, S.A (Spain), Merck & Co., Inc. (Germany), Bausch Health (Canada), Sandoz International GmbH (Germany), Pfizer Inc. (U.S.), AstraZeneca (U.K.), Sanofi (France), Bayer AG (Germany), McKesson Corporation (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Medtronic (Ireland), AbbVie Inc. (U.S.), GALDERMA LABORATORIES, L.P. (U.S.), Novartis AG (Switzerland), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.) and Mylan N.V. (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The topical corticosteroids market is segmented on the basis of molecule name, potency class, medication type, application, distribution channel, and end user.
- On the basis of molecule name, the topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, others. Triamcinolone acetonide dominates the market due to its wide range of applications in various therapeutic areas, including dermatology, allergies, and inflammatory conditions. It is a potent corticosteroid known for its effectiveness and safety profile, making it a preferred choice among healthcare professionals and patients in the forecast period of 2023 to 2030.
In 2023, Triamcinolone acetonide dominates the molecule segment of the market
In 2023, Triamcinolone acetonide dominates the molecule segment of the market owing to its broad range of therapeutic uses in various fields, such as dermatology, allergies, and inflammatory diseases. It is a strong corticosteroid that is popular with patients and healthcare providers due to its effectiveness and safety profile in the forecast period of 2023-2030.
- On the basis of potency class, the topical corticosteroids market is segmented into ultra-high, high, moderate, and low. Moderate dominates the market due to its balanced efficacy and safety profile. Moderate potency medications strike a good balance between effectiveness and potential side effects, making them suitable for a wide range of conditions and patient populations in the forecast period of 2023 to 2030.
- On the basis of medication type, the topical corticosteroids market is segmented into ointments, creams, liquid and solutions, lotions, gel, oils, pastes, sprays, others. The creams dominates the market due to their versatile application and ease of use. Creams offer a good balance between moisture and absorption, making them suitable for a wide range of skin conditions and providing a convenient delivery method for topical medications in the forecast period of 2023 to 2030.
- On the basis of application, the topical corticosteroids market is segmented into acne, dermatitis, Psoriasis, skin infection, hyperpigmentation, melasma, others. Acne dominates the market due to the high prevalence of acne-related skin conditions worldwide. Acne affects a large population, and there is a growing demand for effective treatments, making it a dominant segment in the forecast period of 2023 to 2030.
In 2023, Acne dominates the application segment of the global topical corticosteroids market
In 2023, Acne dominates the application segment of the global topical corticosteroids market owing to the widespread prevalence of acne and the desire for clear, healthy skin. Various products and treatments target acne, addressing its causes and providing solutions for individuals of all ages in the forecast period of 2023 to 2030.
- On the basis of distribution channel, the topical corticosteroids market is segmented into hospital pharmacies, pharmacy stores, online pharmacies, others. The distribution channel segment "Pharmacy Stores" dominates the market due to their widespread availability, established customer base, and ability to provide personalized recommendations and guidance to customers. Pharmacy stores offer convenience and accessibility for purchasing topical corticosteroid medications, contributing to their dominance in the market in the forecast period of 2023 to 2030.
- On the basis of end user, the topical corticosteroids market is segmented into hospital, dermatology clinics, homecare, and others. Dermatology Clinics dominates the market due to the specialized nature of dermatological treatments and the expertise of dermatologists in prescribing and administering topical corticosteroid medications. Dermatology clinics provide a dedicated environment for comprehensive skin care, making them a preferred choice for patients seeking treatment for various skin conditions in the forecast period of 2023 to 2030.
Major Players
Data Bridge Market Research recognizes the following companies as the major topical corticosteroids market players in topical corticosteroids market are AstraZeneca (U.K.), Sanofi (France), Bayer AG (Germany), McKesson Corporation (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Medtronic (Ireland), AbbVie Inc. (U.S.)
Market Development
- In 2022, Lebrikizumab from Lilly and topical corticosteroids showed appreciable reductions in the severity of the atopic dermatitis condition.
- In 2022, A pilot study examining vamorolone as a potential treatment for Becker muscular dystrophy (BMD) dosed its first participant (BMD). ReveraGen BioPharma has been researching the steroid drug as a potential treatment for different types of muscular dystrophy.
Regional Analysis
Geographically, the countries covered in the topical corticosteroids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the topical corticosteroids market during the forecast period 2023-2030
North America's dominance in the topical corticosteroids market can be attributed to its well-developed healthcare infrastructure and favorable reimbursement policies. The region's advanced healthcare system ensures widespread access to dermatological treatments, including topical corticosteroids. Additionally, favorable reimbursement policies in North America facilitate affordable access to these medications, encouraging their utilization. This combination of robust healthcare infrastructure and reimbursement support creates a conducive environment for the growth of the topical corticosteroids market in North America.
Asia-Pacific is estimated to be the fastest-growing region in the topical corticosteroids market in the forecast period 2023-2030
Asia-Pacific is poised to experience the highest growth rate in the topical corticosteroids market from 2023 to 2030. The region's anticipated growth is driven by factors such as the increasing incidence of various cancers, including bladder, esophagus, liver, and pancreas. Additionally, the presence of major manufacturers across the U.S. fosters market expansion. Technological advancements in healthcare, coupled with rising foreign investment, further contribute to the growth of the topical corticosteroids market in the Asia-Pacific region.
For more detailed information about the topical corticosteroids market report, click here – https://www.databridgemarketresearch.com/reports/global-topical-corticosteroids-market
